- Home
- CADL vs MIR Comparison
CADL vs MIR Comparison
Compare CADL & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- MIR
- Stock Information
- Founded
- CADL 1999
- MIR 2005
- Country
- CADL United States
- MIR United States
- Employees
- CADL N/A
- MIR N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- MIR Industrial Machinery/Components
- Sector
- CADL Health Care
- MIR Technology
- Exchange
- CADL Nasdaq
- MIR Nasdaq
- Market Cap
- CADL 252.0M
- MIR 5.0B
- IPO Year
- CADL 2021
- MIR N/A
- Fundamental
- Price
- CADL $5.12
- MIR $20.71
- Analyst Decision
- CADL Strong Buy
- MIR Strong Buy
- Analyst Count
- CADL 5
- MIR 4
- Target Price
- CADL $21.40
- MIR $18.75
- AVG Volume (30 Days)
- CADL 923.9K
- MIR 3.8M
- Earning Date
- CADL 08-12-2025
- MIR 07-31-2025
- Dividend Yield
- CADL N/A
- MIR N/A
- EPS Growth
- CADL N/A
- MIR N/A
- EPS
- CADL N/A
- MIR N/A
- Revenue
- CADL N/A
- MIR $870,200,000.00
- Revenue This Year
- CADL N/A
- MIR $6.45
- Revenue Next Year
- CADL N/A
- MIR $7.51
- P/E Ratio
- CADL N/A
- MIR N/A
- Revenue Growth
- CADL N/A
- MIR 7.25
- 52 Week Low
- CADL $3.79
- MIR $9.11
- 52 Week High
- CADL $14.60
- MIR $22.21
- Technical
- Relative Strength Index (RSI)
- CADL 48.58
- MIR 57.76
- Support Level
- CADL $4.73
- MIR $20.21
- Resistance Level
- CADL $5.24
- MIR $22.21
- Average True Range (ATR)
- CADL 0.29
- MIR 0.73
- MACD
- CADL 0.00
- MIR -0.12
- Stochastic Oscillator
- CADL 64.92
- MIR 47.55
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.